Production (Stage)
Indaptus Therapeutics, Inc.
INDP
$0.3426
-$0.0007-0.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.15% | 2.60% | 1.21% | -7.71% | 1.54% |
| Total Depreciation and Amortization | -100.00% | -41.67% | -16.67% | 0.00% | 6.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.65% | -9.03% | 18.17% | 28.57% | 3.74% |
| Change in Net Operating Assets | 566.75% | 175.72% | 333.37% | 104.40% | 95.01% |
| Cash from Operations | -8.52% | 8.07% | 11.41% | 8.14% | 17.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -43.19% | 230.57% |
| Cash from Investing | -- | -- | -100.00% | -43.19% | 230.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,476.55% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5,270.00% | -- | -- | -- | -- |
| Cash from Financing | 2,299.78% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -299.24% | -302.81% | -192.84% | -245.83% | 111.12% |